BUCCAL APPLICATION SYSTEM COMPRISING 17A-ESTRADIOL
The invention relates to application systems for buccal application, comprising 17a-estradiol in a dosage of 50 to 400 µg, preferably 200 to 400 µg, particularly preferably 300 µg, together with one or more pharmaceutically acceptable additives or media for implementing the treatment or minimization...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention relates to application systems for buccal application, comprising 17a-estradiol in a dosage of 50 to 400 µg, preferably 200 to 400 µg, particularly preferably 300 µg, together with one or more pharmaceutically acceptable additives or media for implementing the treatment or minimization of hot flashes in women having estrogen deficiencies. |
|---|